(Press-News.org) A new study by researchers at the Intermountain Medical Center Heart Institute has found that screening for and treating depression could help to reduce the risk of heart disease in patients with moderate to severe depression.
Researchers at the Intermountain Medical Center Heart Institute, the flagship facility for the Intermountain Healthcare system based in Salt Lake City, analyzed the health records and rates of death, coronary artery disease and stroke of more than 26,000 patients treated by Intermountain over a three-year period.
This is the first study to assess the relative effects of the simultaneous use of antidepressants and cholesterol-lowering drugs among patients with varying levels of depressive symptoms.
Patients completed a nine-question depression screening questionnaire, which assessed such factors as mood, sleep and appetite, to determine their level of depressive symptoms. Based on the questionnaires, researchers identified 5,311 patients as having moderate to severe depression and 21,517 patients as having no to mild depression.
The study, which will be presented March 15 at the American College of Cardiology's 64th Annual Scientific Session in San Diego, found patients with moderate to severe depression who took antidepressants alone had a lower risk of death, coronary artery disease and stroke than patients with moderate to severe depression who did not take antidepressant or statin medications.
Researchers found that taking statins alone or in combination with antidepressants was not associated with a significant risk reduction in this group of patients.
Although the study does not evaluate how antidepressants decreased the risk of cardiovascular disease, the study's lead author Heidi May, PhD, MSPH, a cardiovascular epidemiologist at the Intermountain Medical Center Heart Institute, believes the link could have some relation to behavioral changes.
"Antidepressants might have relevant physiological benefits, but I also think the behavioral changes that improve a person's mood can also improve cardiovascular health," Dr. May said. "This study demonstrates the importance of evaluating patients for depression, not only in terms of improving their mood, but reducing their risk for heart disease."
"Antidepressants were not associated with a reduced cardiovascular risk in people with little or no depression, but in moderately to severely depressed people, antidepressants were shown to significantly improve cardiovascular outcomes," she added.
Patients with moderate to severe depression who were taking antidepressants alone had a 53 percent lower risk of dying, developing coronary artery disease or having a stroke during the three-year follow-up period as compared to patients with moderate to severe depression who were not taking antidepressants or statins.
Moderately to severely depressed patients taking antidepressants alone appeared to also fare better than those taking statins alone or a combination of statins and antidepressants, although these relationships were not directly analyzed.
"We thought we'd see an additive effect--that taking both medications would lower the risk more than either drug alone--but we found that in the more depressed people, the antidepressant really was what made the biggest difference," Dr. May said. "Focus is usually placed more on traditional cardiovascular risk factors and unfortunately, depression is often overlooked. This study adds to the evidence that, when used properly, antidepressants can improve cardiovascular outcomes among those with depressive symptoms."
The researchers excluded from the analysis patients with known cardiovascular disease such as heart failure, coronary artery disease, or a previous heart attack or stroke. They also excluded those who were already taking antidepressants when they completed the questionnaire.
Depression is a known risk factor for cardiovascular disease. An estimated one in 10 adults suffers from depression, according to the Centers for Disease Control and Prevention. Patients with depression have a two- to four-times greater risk of developing cardiovascular disease compared to those without depression.
The analysis accounted for standard cardiovascular risk factors such as diabetes, smoking and hypertension. However, because the study only included information that was available in patients' health records, the researchers were unable to account for other factors such as level of physical activity, changes in habits or non-drug mental health treatment such as psychotherapy.
Dr. May said future studies could help to further refine understanding of the relationships between depression, antidepressants and cardiovascular health.
INFORMATION:
Other members of the study included Tami L. Bair, RN, Brenda Reiss-Brennan, PhD, APRN, Stacey Knight, PhD, Jeffrey L. Anderson, MD, Benjamin D. Horne, PhD, Kimberly D. Brunisholz, PhD, and J. Brent Muhlestein, MD.
A low-cost antiseptic used to cleanse the cord after birth could help reduce infant death rates in developing countries by 12%, a systematic review published in The Cochrane Library suggests. Authors of the review found that when chlorhexidine was used on babies born outside of a hospital, it reduces the number of newborn babies who died or suffer from infections.
A third of deaths in newborn babies are caused by infections. As one of the World Health Organisation's Essential Medicines, chlorhexidine has been used in hospitals and other medical settings to prevent bacterial ...
More young people than ever are getting most of their information about sexual matters from school, but the majority feel they are not getting all the information they need, and men in particular are missing out, according to new research published in BMJ Open.
The findings come from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), the largest scientific study of sexual health and lifestyles in Britain. The research was carried out by UCL (University College London), the London School of Hygiene & Tropical Medicine, and NatCen Social Research. ...
CHICAGO --- Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.
One of the participants in a new Northwestern Medicine study who suffered from painful diabetic neuropathy (PDN), Wenckowski finally found relief from the constant foot pain that required him to wear shoes at all times, even to the beach.
The study found that those with PDN who received two low dose rounds of a non-viral gene therapy called VM202 had significant improvement of their pain that lasted for months.
"I ...
Methane is one hot gas. It's a prominent component of natural gas, an important atmospheric gas, and a product of both biology and chemical reactions. Its presence was recently confirmed in the atmosphere of Mars by NASA's Curiosity Rover and it has made the news both as a critical greenhouse gas and as a groundwater contaminant resulting from fracking. Yet, while methane seems to be everywhere, many questions remain about the reactions that produce and consume this high-energy compound.
"Deciphering the many pathways by which methane is produced is one of the holy grails ...
For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. A team of scientists at the Broad Institute and MIT's David H. Koch Institute for Integrative Cancer Research have pioneered the use of this technology to "knock out," or turn off, all genes across the genome systematically in an animal model of cancer, revealing genes involved in tumor evolution and metastasis and paving the way for similar studies in other cell types and diseases. The work appears online March 5 in Cell.
"Genome-scale ...
A molecule found in some plants can combat weight gain induced by a high-fat diet, but only in female mice, not males. 7,8-dihydroxyflavone (7,8-DHF) is thought to mimic the effects of a growth factor induced by exercise.
Emory researchers led by Keqiang Ye, PhD, have shown that female mice treated with 7,8-DHF could consume a high-fat diet without gaining weight. In the mice, 7,8-DHF could increase energy expenditure by acting on muscle cells, without suppressing appetite.
"An equivalent diet pill in humans would allow people to maintain a healthy weight, despite a ...
Did you know that our body produces its own marijuana-like compound to protect us against anxiety? A study led by Ottawa researchers, published today in Neuron, reveals a new biological pathway that regulates this system and suggests that a drug currently in clinical trials to treat obesity might also provide an attractive way to combat anxiety disorders.
"Anxiety and obesity are growing problems in society," said Dr. Hsiao-Huei Chen, associate professor of medicine at the University of Ottawa and a senior scientist at the Ottawa Hospital Research Institute. "Not only ...
Methane is a potent greenhouse gas, second only to carbon dioxide in its capacity to trap heat in Earth's atmosphere for a long time. The gas can originate from lakes and swamps, natural-gas pipelines, deep-sea vents, and livestock. Understanding the sources of methane, and how the gas is formed, could give scientists a better understanding of its role in warming the planet.
Now a research team led by scientists at MIT and including colleagues from the Woods Hole Oceanographic Institution, the University of Toronto, and elsewhere has developed an instrument that can ...
RIVERSIDE, Calif. - Soybean oil accounts for more than 90 percent of all the seed oil production in the United States. Genetically modified (GM) soybean oil, made from seeds of GM soybean plants, was recently introduced into the food supply on the premise that it is healthier than conventional soybean oil.
But is that premise true?
Just barely, say scientists at the University of California, Riverside and their colleagues at UC Davis. The researchers compared the effects of both oils in experiments performed in the lab on mice. They found that the GM soybean oil is ...
Astronomers have glimpsed a far off and ancient star exploding, not once, but four times.
The exploding star, or supernova, was directly behind a cluster of huge galaxies, whose mass is so great that they warp space-time. This forms a cosmic magnifying glass that creates multiple images of the supernova, an effect first predicted by Albert Einstein's General Theory of Relativity 100 years ago.
Dr Brad Tucker from The Australian National University (ANU) says it's a dream discovery for the team.
"It's perfectly set up, you couldn't have designed a better experiment," ...
